Spirometry and Methacholine Challenge Test in Asthmatic Children Age 3-6years
NCT00550758 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84
Last updated 2007-10-30
Summary
Rational: The possible contribution of methacholine challenge test via spirometry to the clinical diagnosis of young children with various respiratory symptoms, the most appropriate spirometry index, and the proper cutoff point concentration that will define airway sensitivity have not yet been explored. Objectives: To assess airway reactivity by spirometry in a large group of children aged 3-6years with various respiratory symptoms.
Conditions
- Asthma
- Recurrent Cough
Interventions
- DRUG
-
Methachoine
inhalation of triple-concentration increments (0.06 to13.9mg/ml/methacholine)
- DEVICE
-
spirometry
spirometry
Sponsors & Collaborators
-
Rambam Health Care Campus
lead OTHER
Principal Investigators
-
Lea Bentur, MD · Rambam Health Care Campus
-
Daphna Vilozni, PhD · Rambam Health Care Campus
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 3 Years
- Max Age
- 6 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-05-31
- Completion
- 2007-04-30
More Related Trials
-
Extended Safety Study of Montelukast in Infants and Young Children With Chronic Asthma (0476-232)
NCT00943397 ·Status: COMPLETED ·Phase: PHASE3
-
Intermittent and Daily Dosing for Episodic (Periodic) Asthma (0476-302)(COMPLETED)
NCT00337675 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma
NCT00213252 ·Status: COMPLETED ·Phase: PHASE2
-
Chronic Asthma Study in 2- to 5-Year-Old Patients (MK0476-072 )
NCT00968201 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Inhaled Montelukast (MK-0476) in Participants With Mild or Moderate Asthma (MK-0476-380 AM3)(COMPLETED)
NCT00636207 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Montelukast in Asthma in Children
NCT01266772 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
NCT01502371 ·Status: COMPLETED ·Phase: PHASE2
-
Response of FeNO, Small Airway Dysfunction and Lung Heterogeneity to 2-week Montelukast Treatment in Asthmatic Children.
NCT01581710 ·Status: COMPLETED ·Phase: NA
-
The Effect of Montelukast on Difficulty in Breathing After Exercise in Pediatric Patients (MK0476-377)(COMPLETED)
NCT00534976 ·Status: COMPLETED ·Phase: PHASE4
-
Investigation of Lung Ventilation Inhomogeneity in Pediatric Asthma
NCT01095354 ·Status: COMPLETED
-
Exercise Induced Bronchospasm in Children
NCT00273689 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation Montelukast in the Treatment of Status Asthmaticus
NCT01770899 ·Status: UNKNOWN ·Phase: NA
-
A Study of MK0476 in the Treatment of Asthma Patients Aged 2-5 Years (0476-907)
NCT00700661 ·Status: COMPLETED ·Phase: PHASE3
-
Pediatric ACTION3 (Identify, Treat, Control): Effectiveness of Adding Montelukast in Pediatric Subjects With Uncontrolled Asthma (0476-385)
NCT00832455 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Addition of Oral Montelukast to Standard Treatment in Acute Moderate to Severe Asthma in Children
NCT00565955 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of 2 Doses of MAP0010 in Asthmatic Children
NCT00697697 ·Status: TERMINATED ·Phase: PHASE3
-
Pragmatic RCT of High-dose Oral Montelukast for Moderate and Severe Pediatric Acute Asthma Exacerbations
NCT03277170 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303)
NCT00540839 ·Status: WITHDRAWN ·Phase: PHASE3
-
Study of Efficacy and Long-Term Safety of Mometasone Furoate in Combination With Formoterol Fumarate Versus Mometasone Furoate in Children (5 to 11 Years of Age) With Persistent Asthma (MK-0887A-087)
NCT02741271 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Montelukast Therapy in Obstructive Sleep Apnea(OSA) Children
NCT01027806 ·Status: TERMINATED ·Phase: PHASE4
-
Exercise Challenge Test in 3-6 Years Old Asthmatic Children
NCT00442715 ·Status: COMPLETED
-
A Mechanistic Study to Evaluate the Efficacy of Montelukast on Airway Function in Asthma
NCT01841164 ·Status: UNKNOWN ·Phase: NA
-
Montelukast Back to School Asthma Study (0476-340)
NCT00461032 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Pk Study in 1- to 3- Month-Old Children With Bronchiolitis (0476-297)
NCT00394160 ·Status: COMPLETED ·Phase: PHASE2
-
Montelukast in Children With Wheezing
NCT00775697 ·Status: UNKNOWN ·Phase: PHASE4